Overview

Calf Deep Vein Thrombosis Treatment Trial

Status:
Terminated

Trial end date:
2019-06-03

Target enrollment:

Participant gender:

Summary

The primary objective is to evaluate whether apixaban is more effective in treating patients with isolated calf vein thrombosis (DVT) than serial imaging of the DVT for preventing thrombus spread, pulmonary embolism (PE) and/or recurring DVTs.

Phase:

Phase 4

Details

Lead Sponsor:

Mayo Clinic

Collaborators:

Bristol-Myers Squibb
Pfizer

Treatments:

Apixaban